It seems that there is no content provided for summarization. Please provide the text you would like me to summarize.
NVO has been in the news recently: Faruqi & Faruqi is urging investors who lost money in Novo Nordisk from November 2, 2022, to December 19, 2024, to reach out by March 25, 2025. Novo Nordisk plans to sell its weight-loss drug Wegovy directly to US consumers for $499 per month, while facing competition from Eli Lilly.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
